Literature DB >> 8350046

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.

A D Luster1, P Leder.   

Abstract

IP-10 is a member of the -C-X-C-chemokine superfamily of proinflammatory cytokines whose secretion is induced by interferon gamma (IFN-gamma) and lipopolysaccharide (LPS). To date no function has been described for IP-10. We have genetically engineered tumor cells to secrete high levels of murine IP-10 and demonstrate that while IP-10 has no effect on the growth of these tumor cells in culture, it elicits a powerful host-mediated antitumor effect in vivo. The IP-10 antitumor response is T lymphocyte dependent, non-cell autonomous, and appears to be mediated by the recruitment of an inflammatory infiltrate composed of lymphocytes, neutrophils, and monocytes. These results document an important biologic property of IP-10 and raise the possibility that some of the T cell-directed effects of IFN-gamma and LPS may be mediated by this chemokine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350046      PMCID: PMC2191174          DOI: 10.1084/jem.178.3.1057

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.

Authors:  A D Luster; J C Unkeless; J V Ravetch
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

2.  Role of an RNA cleavage/poly(A) addition site in the production of membrane-bound and secreted IgM mRNA.

Authors:  D Danner; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  Construction and applications of a highly transmissible murine retrovirus shuttle vector.

Authors:  C L Cepko; B E Roberts; R C Mulligan
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

4.  Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development.

Authors:  A Leder; P K Pattengale; A Kuo; T A Stewart; P Leder
Journal:  Cell       Date:  1986-05-23       Impact factor: 41.582

5.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.

Authors:  H Potter; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  A translocated human c-myc oncogene is altered in a conserved coding sequence.

Authors:  W Murphy; J Sarid; R Taub; T Vasicek; J Battey; G Lenoir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

7.  Tumors secreting human TNF/cachectin induce cachexia in mice.

Authors:  A Oliff; D Defeo-Jones; M Boyer; D Martinez; D Kiefer; G Vuocolo; A Wolfe; S H Socher
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

8.  Immunoglobulin gene expression in transformed lymphoid cells.

Authors:  V T Oi; S L Morrison; L A Herzenberg; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

9.  Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure.

Authors:  B Seed; A Aruffo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  91 in total

1.  Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.

Authors:  Asa Andersson; Minu K Srivastava; Marni Harris-White; Min Huang; Li Zhu; David Elashoff; Robert M Strieter; Steven M Dubinett; Sherven Sharma
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

2.  Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis.

Authors:  V C Asensio; I L Campbell
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  IFN-γ: A cytokine at the right time, is in the right place.

Authors:  J Daniel Burke; Howard A Young
Journal:  Semin Immunol       Date:  2019-06-17       Impact factor: 11.130

4.  CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance.

Authors:  Jeffrey A Deiuliis; Steve Oghumu; Dheeraj Duggineni; Jixin Zhong; Jessica Rutsky; Ambar Banerjee; Bradley Needleman; Dean Mikami; Vimal Narula; Jeffrey Hazey; Abhay R Satoskar; Sanjay Rajagopalan
Journal:  Obesity (Silver Spring)       Date:  2014-03-27       Impact factor: 5.002

5.  The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3.

Authors:  H Soto; W Wang; R M Strieter; N G Copeland; D J Gilbert; N A Jenkins; J Hedrick; A Zlotnik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

6.  Regulation of pulmonary fibrosis by chemokine receptor CXCR3.

Authors:  Dianhua Jiang; Jiurong Liang; Jennifer Hodge; Bao Lu; Zhou Zhu; Shuang Yu; Juan Fan; Yunfei Gao; Zhinan Yin; Robert Homer; Craig Gerard; Paul W Noble
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 7.  The chemokine receptors CXCR4 and CXCR3 in cancer.

Authors:  Amy M Fulton
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

8.  Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.

Authors:  Ivaylo Gentschev; Ulrike Donat; Elisabeth Hofmann; Stephanie Weibel; Marion Adelfinger; Viktoria Raab; Martin Heisig; Nanhai Chen; Yong A Yu; Jochen Stritzker; Aladar A Szalay
Journal:  J Biomed Biotechnol       Date:  2010-04-01

9.  Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models.

Authors:  Hideyuki Nakashima; Toshio Fujisawa; Syed R Husain; Raj K Puri
Journal:  J Transl Med       Date:  2010-11-10       Impact factor: 5.531

10.  CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Authors:  Gwladys Zabouo; Anne-Marie Imbert; Jocelyne Jacquemier; Pascal Finetti; Thomas Moreau; Benjamin Esterni; Daniel Birnbaum; François Bertucci; Christian Chabannon
Journal:  Breast Cancer Res       Date:  2009-01-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.